Cannabis Company Secures $3.5 Million Funding Commitment

Bright Green Corporation (Nasdaq: BGXX), a company involved in the production, market, and distribution of Schedule I-V plant-based drugs, including opium and cannabis, recently made significant strides in securing financial resources to advance its commercialization efforts. The company has announced the acquisition of a $3.5 million funding commitment under an existing line of credit and has engaged an investment bank to seek an additional $15 million in debt financing. These financial developments reflect Bright Green's efforts to enhance its operational capabilities and expand its footprint in the pharmaceutical industry. $Bright Green (BGXX.US)$